PU-H71-d6

What is PU-H71-d6

PU-H71-d6 is a cutting-edge, deuterated small molecule inhibitor designed to target and disrupt the function of heat shock protein 90 (HSP90), a key chaperone protein involved in cancer cell survival and proliferation. By selectively binding to HSP90, PU-H71-d6 inhibits its activity, leading to the degradation of oncogenic client proteins and ultimately inducing cancer cell death. The deuterium substitution enhances the molecule's metabolic stability and pharmacokinetic profile, improving its therapeutic potential. PU-H71-d6 is being investigated for its efficacy in treating a variety of cancers, particularly those resistant to conventional therapies, offering a promising approach to precision oncology and improved patient outcomes.

Preparation Process: PU-H71-d6 can be prepared by deuterating PU-H71, a purine scaffold-based HSP90 inhibitor. The synthesis involves replacing six hydrogen atoms with deuterium at specific positions, typically using deuterated reagents like D2O or deuterated solvents (e.g., CD3OD). Key steps include: 1. **Deuteration of Precursors**: Start with a deuterated purine derivative or introduce deuterium via hydrogen-deuterium exchange under acidic or basic conditions. 2. **Coupling Reactions**: React the deuterated purine core with a deuterated or non-deuterated side chain using standard coupling reagents (e.g., EDC, DCC). 3. **Purification**: Isolate PU-H71-d6 via column chromatography or HPLC, ensuring >98% deuterium incorporation (confirmed by LC-MS or NMR). Deuterated intermediates (e.g., CD3I) may be used for methyl group deuteration.

Usage Scenarios: PU-H71-d6, a deuterated analog of the HSP90 inhibitor PU-H71, is primarily used in biomedical research for studying cancer therapeutics and protein folding mechanisms. Its deuterium labeling enhances metabolic stability, making it valuable for pharmacokinetic and pharmacodynamic studies via mass spectrometry. Researchers utilize PU-H71-d6 as an internal standard in quantitative assays to improve accuracy in drug metabolism and distribution analyses. It aids in tracing the parent compound’s behavior in biological systems, enabling precise measurement of drug concentrations in tissues and plasma. Additionally, PU-H71-d6 supports investigations into HSP90’s role in oncogenic protein stabilization, offering insights into targeted cancer therapies.

PU-H71-d6 Basic Info

PU-H71-d6 Price